Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
Lamprini Veneti, Elina Seppälä, Margrethe Larsdatter Storm, et al.
PLoS ONE (2021) Vol. 16, Iss. 10, pp. e0258513-e0258513
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
Lixin Lin, Ying Liu, Xiujuan Tang, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 217
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 145
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
Elina Seppälä, Lamprini Veneti, Jostein Starrfelt, et al.
Eurosurveillance (2021) Vol. 26, Iss. 35
Open Access | Times Cited: 64
SARS-CoV-2 Variants and Clinical Outcomes: A Systematic Review
Indira R. Mendiola‐Pastrana, Eduardo López‐Ortiz, José G. Río de la Loza-Zamora, et al.
Life (2022) Vol. 12, Iss. 2, pp. 170-170
Open Access | Times Cited: 61
Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 50
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
Saskia Meyer, Isaac Blaas, Ravi Chand Bollineni, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111995-111995
Open Access | Times Cited: 28
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
Katherine S. Lee, Ting Y. Wong, Brynnan P. Russ, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273430-e0273430
Open Access | Times Cited: 36
Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants
Dídac Florensa, Jordi Nofre, Radu Spaimoc, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway
Robert Whittaker, Margrethe Greve‐Isdahl, Håkon Bøas, et al.
PEDIATRICS (2022) Vol. 150, Iss. 3
Open Access | Times Cited: 33
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Zhilu Yuan, Zengyang Shao, Lijia Ma, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1994-1994
Open Access | Times Cited: 22
Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent
David J. Pascall, Elen Vink, Rachel Blacow, et al.
Journal of Infection (2023) Vol. 87, Iss. 2, pp. 128-135
Open Access | Times Cited: 19
A stochastic particle extended SEIRS model with repeated vaccination: Application to real data of COVID‐19 in Italy
Vasileios E. Papageorgiou, George Tsaklidis
Mathematical Methods in the Applied Sciences (2024) Vol. 47, Iss. 7, pp. 6504-6538
Open Access | Times Cited: 7
Excess mortality in Denmark, Finland, Norway and Sweden during the COVID-19 pandemic 2020–2022
Ingeborg Forthun, Christian Madsen, Louise Emilsson, et al.
European Journal of Public Health (2024) Vol. 34, Iss. 4, pp. 737-743
Open Access | Times Cited: 7
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
Lamprini Veneti, Beatriz Valcárcel Salamanca, Elina Seppälä, et al.
International Journal of Infectious Diseases (2021) Vol. 115, pp. 178-184
Open Access | Times Cited: 35
An improved epidemiological-unscented Kalman filter (hybrid SEIHCRDV-UKF) model for the prediction of COVID-19. Application on real-time data
Vasileios E. Papageorgiou, George Tsaklidis
Chaos Solitons & Fractals (2022) Vol. 166, pp. 112914-112914
Open Access | Times Cited: 23
SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the Literature
Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses (2024) Vol. 16, Iss. 8, pp. 1222-1222
Open Access | Times Cited: 4
Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins
Yanlei Zhu, Flavio Alvarez, Nicolas Wolff, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 17
Modeling geographic vaccination strategies for COVID-19 in Norway
Louis Yat Hin Chan, Gunnar Rø, J. E. Midtbø, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011426-e1011426
Open Access | Times Cited: 3
Health system impacts of SARS-CoV − 2 variants of concern: a rapid review
Justine Dol, Leah Boulos, Mari Somerville, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
Katherine S. Lee, Ting Y. Wong, Brynnan P. Russ, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Unravelling the link between SARS-CoV-2 mutation frequencies, patient comorbidities, and structural dynamics
Amirah Azzeri, Nurul Azmawati Mohamed, Saarah Huurieyah Wan Rosli, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0291892-e0291892
Open Access | Times Cited: 2
Early-stage spatial disease surveillance of novel SARS-CoV-2 variants of concern in Germany with crowdsourced data
Timo Mitze, Johannes Rode
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022
Tommy Nyberg, Peter Bager, Ingrid Bech Svalgaard, et al.
Eurosurveillance (2023) Vol. 28, Iss. 36
Open Access | Times Cited: 6
Prevalence and Health Outcomes ofClostridioides difficileInfection During the Coronavirus Disease 2019 Pandemic in a National Sample of United States Hospital Systems
Kelly R. Reveles, Alexa L Frei, Kelsey A. Strey, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top